These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19917373

  • 1. Monitoring of C0 and C2 blood concentrations of cyclosporine on the Roche Hitachi 902 analyzer.
    Yargui L, Berhoune A.
    Transplant Proc; 2009 Nov; 41(9):3713-9. PubMed ID: 19917373
    [Abstract] [Full Text] [Related]

  • 2. [The EMIT Tacrolimus assay: development of application protocol for Roche Hitachi 902 analyzer].
    Yargui L, Berhoune A.
    Ann Biol Clin (Paris); 2008 Nov; 66(6):657-64. PubMed ID: 19091665
    [Abstract] [Full Text] [Related]

  • 3. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R.
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [Abstract] [Full Text] [Related]

  • 5. Automated monitoring of C2 and C0 blood levels of mycophenolic acid and cyclosporine on the Abbott Architect c8000.
    Boer K, Brehmer-Streck S, Deufel T, Schmidt D, Kiehntopf M.
    Clin Biochem; 2007 Oct; 40(15):1163-7. PubMed ID: 17689516
    [Abstract] [Full Text] [Related]

  • 6. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
    Elaerts S, Olejnik Y, Bonardet A, Garrigue V, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 Oct; 37(1):167-71. PubMed ID: 15808583
    [Abstract] [Full Text] [Related]

  • 7. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
    Olejnik Y, Elaerts S, Bonardet A, Chong G, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 Oct; 37(1):172-4. PubMed ID: 15808584
    [Abstract] [Full Text] [Related]

  • 8. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.
    Dias VC, Legatt DF, Yatscoff RW.
    Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
    Huet E, Morand K, Blanchet B, Astier A, Hulin A.
    Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P, Therapeutic Drug Monitoring Group of the French Pharmacological Society.
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [Abstract] [Full Text] [Related]

  • 14. Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation.
    Rodrigo E, Ruiz JC, Angeles de Cos M, Ruiz J, Gago M, Piñera C, Sánchez B, González-Cotorruelo J, Gómez-Alamillo C, Arias M.
    Transplant Proc; 2009 Feb; 41(6):2328-31. PubMed ID: 19715910
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M.
    Transplant Proc; 2004 Feb; 36(1):86-8. PubMed ID: 15013308
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
    Higgins RM, Kanji H, Hernon M, Harrison P, Lam FT, Kashi SH.
    Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859
    [Abstract] [Full Text] [Related]

  • 17. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T.
    Transplantation; 2003 Oct 27; 76(8):1236-8. PubMed ID: 14578761
    [Abstract] [Full Text] [Related]

  • 18. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
    Ren Fail; 2005 Oct 27; 27(4):409-13. PubMed ID: 16060128
    [Abstract] [Full Text] [Related]

  • 19. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 27; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 20. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
    Soylu A, Kavukçu S, Türkmen MA, Kasap B, Soylu A, Bora S, Gülay H.
    Transplant Proc; 2006 Jun 27; 38(5):1286-9. PubMed ID: 16797283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.